TRANSMIT GESELLSCHAFT FUR TECHNOLOGIETRANSFERT MBH

Their core work

TRANSMIT is a professional technology transfer company based in Giessen, Germany, whose core business is bridging the gap between research institutions and commercial markets. They do not develop technology themselves — they specialize in exploitation planning, commercialization strategy, and cluster-building that helps research results reach industry. Their H2020 participation reflects this role: in KETBIO they helped design a cluster model to bring biotech research to market, and in AETHER they contributed exploitation expertise to an advanced space propulsion project. As a dedicated technology transfer office (TTO), they bring process knowledge that most research partners in a consortium lack.

What they specialise in

How they've shifted over time

In their first H2020 project (KETBIO, 2017), TRANSMIT operated squarely within the life sciences domain — biotechnology clusters, research exploitation, knowledge transfer — which is typical TTO territory. By 2019, their second project (AETHER) was a sharp pivot into aerospace, specifically air-breathing electric thrusters for very low Earth orbit satellites, a niche propulsion concept requiring highly specialized technical context. The consistent thread across both is their role as the commercialization and exploitation specialist, but the domain shift from biotech to space propulsion suggests TRANSMIT deliberately positions itself as a domain-agnostic TTO capable of serving any deep-tech field.

TRANSMIT appears to be moving toward higher-complexity, higher-budget deep-tech projects — their AETHER involvement (EUR 400,000) was nearly four times the value of KETBIO, suggesting growing competitiveness in advanced technology sectors beyond traditional life sciences TTO work.

How they like to work

TRANSMIT has never coordinated an H2020 project — they always enter as a participant, contributing a specific function (exploitation, dissemination, market analysis) that research-heavy consortia need but rarely have in-house. With 14 unique partners across 8 countries over just 2 projects, they bring diverse consortium connections despite a small project portfolio. This profile suggests they are a specialist brought in to handle the commercialization layer, not a scientific lead.

Despite only two projects, TRANSMIT has connected with 14 distinct consortium partners across 8 countries, indicating they actively join multi-national consortia rather than working locally. Their network spans both the biotech and aerospace research communities in Europe.

What sets them apart

TRANSMIT occupies an unusual position for a German SME: a professional TTO that has demonstrated willingness to cross into radically different technical domains — from biotechnology clusters to cutting-edge space propulsion — rather than specializing in a single sector. For consortium builders who need an exploitation and commercialization partner without bringing a full research institute on board, TRANSMIT offers lean, focused TTO expertise. Their Giessen base also connects them to the broader Hessian research and innovation ecosystem, including proximity to major German universities.

Highlights from their portfolio

• AETHER
  The largest project by funding (EUR 400,000) and the most technically striking — RAM-EP air-breathing electric propulsion for very low Earth orbit is a frontier aerospace topic, showing TRANSMIT can operate as a TTO partner in deep-tech space projects far outside conventional biotech territory.
• KETBIO
  Represents TRANSMIT's core competency in biotechnology cluster-building and market exploitation, with a direct mandate to connect key enabling technologies to commercial and societal users.